Immediate Impact
1 from Science/Nature 58 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
The interaction of innate immune and adaptive immune system
2024 Standout
Works of Wei‐Hsun Hsu being referenced
Tumor PD-L1 Expression and Clinical Outcomes in Advanced-stage Non-Small Cell Lung Cancer Patients Treated with Nivolumab or Pembrolizumab: Real-World Data in Taiwan
2018
EMT is associated with, but does not drive resistance to ALK inhibitors among EML4‐ALK non‐small cell lung cancer
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Wei‐Hsun Hsu | 198 | 235 | 155 | 20 | 478 | |
| P. Langecker | 58 | 149 | 104 | 26 | 483 | |
| Aruna Dontabhaktuni | 142 | 213 | 150 | 16 | 453 | |
| Sae Bom Lee | 142 | 167 | 191 | 16 | 461 | |
| Ziyang Wang | 112 | 65 | 310 | 37 | 483 | |
| Cory L. Painter | 82 | 188 | 274 | 15 | 463 | |
| Faye Vazvaei | 56 | 109 | 233 | 18 | 446 | |
| Zhennan Gu | 159 | 114 | 213 | 16 | 435 | |
| Raghuveera Kumar Goel | 45 | 139 | 286 | 21 | 492 | |
| Xiaofang Zhao | 72 | 211 | 181 | 26 | 512 | |
| Elizabeth A. Macdonald | 28 | 102 | 266 | 21 | 532 |
All Works
Login with ORCID to disown or claim papers
Loading papers...